Position in CYTK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$170,380
-$424,787 QoQ
Shares Held
2,000
-77.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#371
of 477 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2025CallValue
$190
CallShares
3
PutValue
$6,354
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. CYTK ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NUVL |
Nuvalent, Inc.
|
108,951 | $13,455,448 | |
| 2 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 3 | SGMT |
Sagimet Biosciences Inc.
|
109,250 | $844,502 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
5,000 | $663,650 | |
| 5 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 6 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 7 | VERU |
Veru Inc.
|
105,081 | $328,903 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
8,170 | $318,711 |
All Filings in CYTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,380 | 2,000 | Shares | Defined | 2026-07-08 | |
| 2026-03-31 | $595,167 | 9,030 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $6,354 | 100 | Put | Sole | 2026-01-16 | |
| 2025-12-31 | $334,220 | 5,260 | Shares | Sole | 2026-01-16 | |
| 2025-12-31 | $190 | 3 | Call | Sole | 2026-01-16 | |
| 2025-09-30 | $473,425 | 8,614 | Shares | Defined | 2025-12-15 | |
| 2025-09-30 | $5,496 | 100 | Put | Defined | 2025-12-15 | |
| 2025-09-30 | $1 | 33 | Call | Defined | 2025-12-15 | |
| 2025-06-30 | $426,050 | 12,895 | Shares | Sole | 2025-07-30 | |
| 2025-06-30 | $1,090 | 33 | Call | Sole | 2025-07-30 | |
| 2025-03-31 | $120 | 3 | Call | Sole | 2025-04-17 | |
| 2025-03-31 | $436,262 | 10,855 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $684,196 | 14,545 | Shares | Sole | 2025-01-13 | |
| 2024-12-31 | $11,995 | 255 | Call | Sole | 2025-01-13 | |
| 2024-09-30 | $596,904 | 11,305 | Shares | Sole | 2024-10-18 | |
| 2024-09-30 | $264 | 5 | Put | Sole | 2024-10-18 | |
| 2024-09-30 | $422 | 8 | Call | Sole | 2024-10-18 | |
| 2024-06-30 | $654,115 | 12,073 | Shares | Sole | 2024-08-05 | |
| 2024-06-30 | $595 | 11 | Call | Sole | 2024-08-05 | |
| 2024-06-30 | $270 | 5 | Put | Sole | 2024-08-05 | |
| 2024-03-31 | $704,956 | 10,055 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2 | 30 | Call | Defined | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||